Today's guest is Brandon Rice, Chief Product Officer at Weave. Founded in 2023, Weave Bio is an AI-native regulatory automation management platform redefining regulatory submissions for novel therapeutic candidates. Designed for pharma, biotechs, CROs and consultants, the Weave Platform streamlines regulatory document preparation and lifecycle management by automating initial draft documents, extracting key insights and integrating study data into a seamless, AI-enabled workflow.

The platform accelerates regulatory processes, enabling faster drafting, high-quality reviews and compliance with global standards. AutoIND, widely adopted for preclinical IND submissions, earned the “Biotech AI Innovation of the Year” award. With AutoCT, Weave expanded capabilities into clinical-stage submissions, building the foundation for a singular AI workbench for the entire therapy lifecycle.

In this episode, Brandon talks about:

His journey from bioinformatics to impactful startups and product innovation,

Their focus on automating regulatory filings for impactful drug development,

Streamlining FDA filings with AI cutting time and costs dramatically,

Small teams with customer-driven and collaborative product development,

Expanding regulatory support to accelerate drug development,

Scaling engineering and customer success for AI-powered software,

Hiring mission-driven, product-minded individuals for meaningful impact